HomeInsightsPB

Sun Pharmaceuticals Industries Ltd PB Ratio

Sun Pharmaceuticals Industries Ltd PB Ratio

stocks purchased

₹ 5.2 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

28.9 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

PB

6.2

Last updated on: Nov 07, 2024

Key Highlights

  • The P/B Ratio of Sun Pharmaceuticals Industries Ltd is 6.2 as of 07 Nov 24.
  • The P/B Ratio of Sun Pharmaceuticals Industries Ltd changed from 4.6 on March 2022 to 6.1 on March 2024 . This represents a CAGR of 9.86% over 3 years. .

Historical P/B Ratio of Sun Pharmaceuticals Industries Ltd

No data available

Company Fundamentals for Sun Pharmaceuticals Industries Ltd

Market Cap

429,840 Cr

EPS

46.7

P/E Ratio (TTM) *

38.3

P/B Ratio (TTM) *

6.2

Day’s High *

1849.95

Day’s Low

1778.3

DTE *

0.0

ROE *

16.0

52 Week High

1960.2

52 Week Low

1167.05

ROCE *

18.1

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Sun Pharmaceuticals Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20241791.5
06 Nov 20241827.25
05 Nov 20241803.25
04 Nov 20241808.8
01 Nov 20241858.7
31 Oct 20241849.05
30 Oct 20241852.45
29 Oct 20241870.9
28 Oct 20241902.65
25 Oct 20241860.25

SWOT Analysis Of Sun Pharmaceuticals Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sun Pharmaceuticals Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Sun Pharmaceuticals Industries Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Sun Pharmaceuticals Industries Ltd64,29,840
Divis Laboratories Ltd5071,58,179
Cipla Ltd3601,27,063
Mankind Pharma Ltd2691,09,234
Dr Reddys Laboratories Ltd3221,07,398
Torrent Pharmaceuticals Ltd2221,06,924

Key Valuation Metric of Sun Pharmaceuticals Industries Ltd

Share Price

₹1,792

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Revenue of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical EBITDA of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Net Profit of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Sun Pharmaceuticals Industries Ltd News Hub

News

Sun Pharma tumbles after US court halts Leqselvi launch

Aa result of the court's decision, Sun Pharma has been temporarily barred from launching L...

Read more

04 Nov 202411:14

News

Sun Pharmaceuticals Industries Ltd up for third straight session

Sun Pharmaceuticals Industries Ltd is up for a third straight session today. The stock is ...

Read more

28 Oct 202413:05

News

Sun Pharma gains after Q2 PAT climbs 28% YoY to Rs 3,040 cr

Profit before tax was at Rs 3,597.88 crore in Q2 FY25, registering a growth of 28.91% on Y...

Read more

28 Oct 202416:01

News

Sun Pharmaceuticals Industries to hold board meeting

Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Compan...

Read more

09 Oct 202417:30

News

Sun Pharma inks global licensing agreement with Philogen

Sun Pharmaceutical Industries and Philogen S.p.A (Philogen) today announced that they have...

Read more

01 Oct 202410:34

News

Sun Pharma inks exclusive pact with Philogen for commercializing anti-cancer drug Fibromun

Philogen is an Italian-Swiss company active in the biotechnology sector, specialized in th...

Read more

01 Oct 202410:34

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

July 2024

PPT

May 2024

Transcript

Mar 2024

PPT

Feb 2024

Transcript

Jan 2024

PPT

Nov 2023

Transcript

Sep 2023

PPT

May 2023

Transcript

Apr 2023

PPT

Nov 2022

Transcript

Sep 2022

PPT

Aug 2022

Transcript

June 2022

Transcript

Mar 2022

PPT

Feb 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

June 2021

Transcript

Jan 2021

Transcript

Oct 2020

Transcript

FAQs for PB Ratio of Sun Pharmaceuticals Industries Ltd

What is the PB ratio of Sun Pharmaceuticals Industries Ltd?

The current PB ratio of Sun Pharmaceuticals Industries Ltd is 6.22. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Sun Pharmaceuticals Industries Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Sun Pharmaceuticals Industries Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Sun Pharmaceuticals Industries Ltd calculated?

The PB ratio of Sun Pharmaceuticals Industries Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Sun Pharmaceuticals Industries Ltd?

A high PB ratio suggests that Sun Pharmaceuticals Industries Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Sun Pharmaceuticals Industries Ltd?

A low PB ratio of Sun Pharmaceuticals Industries Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Sun Pharmaceuticals Industries Ltd PB Ratio change over time?

Yes, the PB ratio of Sun Pharmaceuticals Industries Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*